GE HealthCare Technologies Inc (NASDAQ: GEHC)’s stock price has increased by 0.42 compared to its previous closing price of 79.47. However, the company has seen a -10.28% decrease in its stock price over the last five trading sessions. The Motley Fool reported 2024-05-03 that The company remains on track for growth in 2024. Management believes new product introductions will drive growth and margin expansion.
Is It Worth Investing in GE HealthCare Technologies Inc (NASDAQ: GEHC) Right Now?
GE HealthCare Technologies Inc (NASDAQ: GEHC) has a price-to-earnings ratio that is above its average at 23.29x. The stock has a 36-month beta value of 1.48. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GEHC is 424.41M, and at present, short sellers hold a 2.58% of that float. On May 07, 2024, the average trading volume of GEHC was 3.76M shares.
GEHC’s Market Performance
GEHC stock saw a decrease of -10.28% in the past week, with a monthly decline of -9.80% and a quarterly a decrease of 8.70%. The volatility ratio for the week is 3.63%, and the volatility levels for the last 30 days are 2.40% for GE HealthCare Technologies Inc (GEHC). The simple moving average for the past 20 days is -5.64% for GEHC’s stock, with a 4.77% simple moving average for the past 200 days.
Analysts’ Opinion of GEHC
Many brokerage firms have already submitted their reports for GEHC stocks, with HSBC Securities repeating the rating for GEHC by listing it as a “Buy.” The predicted price for GEHC in the upcoming period, according to HSBC Securities is $100 based on the research report published on February 15, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see GEHC reach a price target of $88, previously predicting the price at $66. The rating they have provided for GEHC stocks is “Neutral” according to the report published on February 12th, 2024.
Jefferies gave a rating of “Hold” to GEHC, setting the target price at $80 in the report published on November 30th of the previous year.
GEHC Trading at -9.54% from the 50-Day Moving Average
After a stumble in the market that brought GEHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.56% of loss for the given period.
Volatility was left at 2.40%, however, over the last 30 days, the volatility rate increased by 3.63%, as shares sank -9.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.41% lower at present.
During the last 5 trading sessions, GEHC fell by -10.28%, which changed the moving average for the period of 200-days by -2.50% in comparison to the 20-day moving average, which settled at $84.17. In addition, GE HealthCare Technologies Inc saw 3.21% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GEHC starting from Jimenez Frank R, who purchase 1,315 shares at the price of $76.52 back on May 01 ’24. After this action, Jimenez Frank R now owns 75,796 shares of GE HealthCare Technologies Inc, valued at $100,624 using the latest closing price.
O’Neill Kevin Michael, the CEO, PDx of GE HealthCare Technologies Inc, sale 15,609 shares at $77.32 during a trade that took place back on Jul 31 ’23, which means that O’Neill Kevin Michael is holding 24,025 shares at $1,206,949 based on the most recent closing price.
Stock Fundamentals for GEHC
Current profitability levels for the company are sitting at:
- 0.12 for the present operating margin
- 0.41 for the gross margin
The net margin for GE HealthCare Technologies Inc stands at 0.08. The total capital return value is set at 0.1. Equity return is now at value 22.33, with 4.85 for asset returns.
Based on GE HealthCare Technologies Inc (GEHC), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 1.31. The interest coverage ratio of the stock is 4.44.
Currently, EBITDA for the company is 3.51 billion with net debt to EBITDA at 2.15. When we switch over and look at the enterprise to sales, we see a ratio of 2.23. The receivables turnover for the company is 4.85for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.01.
Conclusion
To sum up, GE HealthCare Technologies Inc (GEHC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
